Wrinkle Reduction Using Tetrapeptide-68 Contained in an O/W Formulation: A Randomized Double-Blind Placebo-Controlled

Sung-Gyu Lee1, Sang-Moon Kang2, Hyun Kang1

  • 1Department of Medical Laboratory Science, College of Health Science, Dankook University, Cheonan-si 31116, Republic of Korea.

Pharmaceutics
|August 29, 2024
PubMed
Summary

Tetrapeptide-68, a peptide derived from Loricrin, effectively reduces periorbital wrinkles in women aged 30-65. This anti-aging peptide shows promising results with no adverse reactions, enhancing skin texture and moisture.